Mercy Hospital Fort Smith is introducing robotic-assisted bronchoscopy, offering safer early detection for lung disease.

There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could ...

Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...

CyPath® Lung test supported recommendation for surveillance strategy, rather than subjecting elderly patient to an invasive, risky and costly biopsy procedure Despite a suspicious nodule during a ...

(Reuters) - A new diagnostic test from Veracyte Inc could help many people avoid risky and costly invasive lung biopsies at a time when millions of American smokers are eligible for lung cancer ...

A procedure that can help spot lung cancer early is now available at a hospital, saving patients long trips out of a county.

A revolutionary AI-powered diagnostic test for chronic obstructive pulmonary disease (COPD) is set to be introduced in GP surgeries across England from 14 April, offering a faster and more accurate ...

Thermo Fisher Scientific has launched a new diagnostic test to help physicians better detect and manage lung transplant rejection. Dubbed the Molecular Microscope Diagnostic System for Lung, the test ...

Surgery is a common treatment for non-small cell lung cancer (NSCLC), particularly when the disease is detected early and the tumor is small and is only in one part of the lung. For small cell lung ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW) today released a study of a complex clinical case in which CyPath® Lung’s real-time assessment of the lung ...

Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.